Abstract
The aim of the studies described in this thesis is to investigate methods to improve the therapeutic efficacy and safety of PCa targeting tracers by comparing and selecting the most optimal PCa targeting tracer, by exploring combined PCa-TRT with radiosensitizing strategies, by analyzing the effects of different therapeutic radionuclides, and lastly by identifying the acute, early and/or late radiotoxic effects caused by PCa-TRT. The results of these studies together have increased the general knowledge of PCa-TRT for PCa cancer, which will aid the development and improvement of the currently clinical available treatment options for PCa patients.
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 21 Mar 2023 |
| Place of Publication | Rotterdam |
| Print ISBNs | 978-94-6419-725-9 |
| Publication status | Published - 21 Mar 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Preclinical studies to improve targeted radionuclide therapy for prostate cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver